Mesothelioma drug slows disease progression in patients with an inactive NF2 gene
Thursday, November 8, 2012 - 23:00
in Health & Medicine
Preliminary findings from the first trial of a new drug for patients with mesothelioma show that it has some success in preventing the spread of the deadly disease in patients lacking an active tumour suppressor gene called NF2.